Cargando…
Travel burden associated with rare cancers: The example of Merkel cell carcinoma
BACKGROUND: There are limited data on the travel burden for cancer patients with rare tumor types, such as Merkel cell carcinoma (MCC). OBJECTIVE: The objective of this study was to understand the travel burden of MCC patients. METHODS: This study used data from an MCC registry at the Seattle Cancer...
Autores principales: | Jain, Rahul, Menzin, Joseph, Lachance, Kristina, McBee, Patrick, Phatak, Hemant, Nghiem, Paul T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536956/ https://www.ncbi.nlm.nih.gov/pubmed/30950224 http://dx.doi.org/10.1002/cam4.2085 |
Ejemplares similares
-
Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East
por: Ascierto, Paolo Antonio, et al.
Publicado: (2021) -
Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study
por: Bhatia, Shailender, et al.
Publicado: (2022) -
The global burden of cancer: priorities for prevention
por: Thun, Michael J., et al.
Publicado: (2010) -
The global burden of thyroid cancer and its attributable risk factor in 195 countries and territories: A systematic analysis for the Global Burden of Disease Study
por: Zhai, Mimi, et al.
Publicado: (2021) -
Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: A systematic analysis of the Global Burden of Disease Study 1990–2017
por: Azadnajafabad, Sina, et al.
Publicado: (2021)